Existing evidence suggests that vasopressin (VP, antidiuretic hormone) release is elevated in several types of experimental hypertension as well as in humans with hypertension. Furthermore, the VP system is hyperresponsive to certain stimuli in rats genetically disposed to spontaneous development of hypertension (e.g. the spontaneously hypertensive rats (SHRs) developed by Okamoto) but relationships between this hyperresponsiveness and the hypertension is unclear. Therefore, experiments are proposed to evaluate this relationship. Two approaches will be used: 1). The importance of the hyperresponsiveness to the development of hypertension will be evaluated by chronically blocking the vasopressin effects of VP with an analog of VP which has specific pressor antagonist actions. Similarly the contribution of elevated VP release to the maintenance of blood pressure at the different stages of the hypertensive process will be analyzed by acutely infusing the VP pressor antagonist during the development and chronic phases of hypertension. 2). The opposite relationship also will be examined, e.g. the potential role of the hypertension in initiating the hyperresponsiveness of the VP system or in the eventual disappearance of the hyperresponsiveness. This will be evaluated by using three interventions to prevent development of the hypertension and examining the responsiveness of the VP system in rats with these interventions. The interventions employed will be chronic converting enzyme inhibition, intraventricular 6-hydroxydopamine injections, and renal denervation. In rats maintained normotensive with some of these interventions, the responsiveness of the renin-angiotensin system and the NE innervation of VP neurons also will be evaluated, because abnormalities in these factors have also been observed in SHRs.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL028172-06
Application #
3339588
Study Section
Experimental Cardiovascular Sciences Study Section (ECS)
Project Start
1982-01-01
Project End
1988-06-30
Budget Start
1987-01-01
Budget End
1988-06-30
Support Year
6
Fiscal Year
1987
Total Cost
Indirect Cost
Name
University of Rochester
Department
Type
School of Medicine & Dentistry
DUNS #
208469486
City
Rochester
State
NY
Country
United States
Zip Code
14627
Skoog, K M; Blair, M L; Sladek, C D et al. (1990) Area postrema: essential for support of arterial pressure after hemorrhage in rats. Am J Physiol 258:R1472-8
Mangiapane, M L; Skoog, K M; Rittenhouse, P et al. (1989) Lesion of the area postrema region attenuates hypertension in spontaneously hypertensive rats. Circ Res 64:129-35
Sladek, C D; Blair, M L; Sterling, C et al. (1988) Attenuation of spontaneous hypertension in rats by a vasopressin antagonist. Hypertension 12:506-12
Sladek, C D; Chen, Y H; Aravich, P F et al. (1987) Osmotic regulation of vasopressin and renin in spontaneously hypertensive rats. Hypertension 10:476-83
Sladek, C D; Blair, M L; Mangiapane, M (1987) Evidence against a pressor role for vasopressin in spontaneous hypertension. Hypertension 9:332-8
Sladek Jr, J R; Davis, B J; Sladek, C D (1986) Localization of vasopressin-neurophysin and norepinephrine in the supraoptic nucleus of spontaneously hypertensive rats. Brain Res 365:293-304
Clough, R W; Aravich, P F; Sladek, C D (1986) Monosodium glutamate neurotoxicity: a sex-specific impairment of blood pressure but not vasopressin in developing rats. Brain Res Bull 17:51-8
Sladek, C D; Blair, M L; Chen, Y H et al. (1986) Vasopressin and renin response to plasma volume loss in spontaneously hypertensive rats. Am J Physiol 250:H443-52